Michael Reisman
- Role
- Investment Banking Associate at Centerview Partners
- Location
- San Francisco, CA, US
- LinkedIn followers
- 500 followers
Finance & AccountingView LinkedIn profile
About Michael Reisman
mreisman [at] centerview [dot com]
Experience
Investment Banking Associate
Jul 2021 — Present
Healthcare M&A and strategic advisory • $10.8bn sale of Prometheus Biosciences to Merck (closed Jun. 2023) • $5.8bn sale of Global Blood Therapeutics to Pfizer (closed Oct. 2022) • $320mm sale of ViaCyte to Vertex (announced Jul. 2022) • $800mm acquisition of Omniome by PacBio (closed Sep. 2021) • $200mm sale of equity stake in Immunovant to Roivant (closed Aug.
Skills
- Mergers & Acquisitions
- Finance
- Microsoft Office
- Equity Research
- Financial Modeling
- Java
- Microsoft Word
- Wealth Management
- Social Media
- Data Analysis
- Economics
- Investment Banking
- Investments
- Powerpoint
- International Market Analysis
- Portfolio Management
- Public Speaking
- Dcf Valuation
- Social Networking
- Fixed Income Analysis
- Customer Service
- Research
- Microsoft Excel
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.